Medical isotope firm Shine Medical Technologies has signed Harsh Singh as its chief strategy officer and Nathan Schleifer as general counsel.
Singh has 18 years of experience structuring private capital financings, public offerings, and strategic transactions and will be responsible for fundraising, sales, marketing, investor relations, and corporate development, according to Shine.
An attorney with 16 years of legal experience, Schleifer will oversee Shine's global legal, intellectual property, and compliance efforts.
Both positions are newly created roles for the company.
